Published in J Clin Invest on May 01, 1992
The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol (1995) 4.60
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest (1993) 2.89
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest (1999) 1.76
Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A (1994) 1.63
PPARs and the cardiovascular system. Antioxid Redox Signal (2009) 1.28
Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest (1992) 1.20
Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A (1996) 1.10
Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest (1996) 1.02
Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest (1994) 1.00
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol (1994) 1.00
A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res (2005) 1.00
Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol (2001) 0.95
Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J Clin Invest (1993) 0.95
Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages. Biochem J (1996) 0.93
n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Arterioscler Thromb Vasc Biol (2009) 0.91
Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J Clin Invest (1993) 0.91
Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium. J Clin Invest (1997) 0.91
Active macrophage-associated TGF-beta co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol (1995) 0.89
Down-regulation of lipoprotein lipase increases ABCA1-mediated cholesterol efflux in THP-1 macrophages. Biochem Biophys Res Commun (2014) 0.84
Lipoprotein lipase expression in natural killer cells and its role in their cytotoxic activity. Immunology (1994) 0.83
Not the mature 56 kDa lipoprotein lipase protein but a 37 kDa protein co-purifying with the lipase mediates the binding of low density lipoproteins to J774 macrophages. Biochem J (1998) 0.80
Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP. J Lipid Res (2008) 0.79
Hydrolysis products generated by lipoprotein lipase and endothelial lipase differentially impact THP-1 macrophage cell signalling pathways. Lipids (2013) 0.79
Lipopolysaccharide regulation of lipoprotein lipase expression in murine macrophages. Infect Immun (1995) 0.78
Endogenously produced lipoprotein lipase enhances the binding and cell association of native, mildly oxidized and moderately oxidized low-density lipoprotein in mouse peritoneal macrophages. Biochem J (1999) 0.77
Transgenic rabbits expressing human lipoprotein lipase. Cytotechnology (2000) 0.76
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51
Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol (1989) 3.82
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med (1989) 3.31
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis (1989) 2.14
Structure of the human lipoprotein lipase gene. Biochemistry (1989) 1.72
Secretion of lipoprotein lipase by macrophages in culture. J Biol Chem (1981) 1.56
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 1.55
Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry (1988) 1.52
Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb (1991) 1.46
The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J Biol Chem (1983) 1.30
Lipoprotein lipase secretion by human monocyte-derived macrophages. J Clin Invest (1982) 1.26
A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res (1973) 1.25
Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol (1990) 1.19
Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem (1988) 1.19
Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim Biophys Acta (1990) 1.18
Lipoprotein lipase secretion by human monocytes and rabbit alveolar macrophages in culture. Proc Natl Acad Sci U S A (1982) 1.13
Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. J Lipid Res (1990) 0.98
Lipoprotein lipase activity in bovine aorta. Proc Soc Exp Biol Med (1975) 0.95
Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. J Lipid Res (1987) 0.94
Transcriptional activation of the lipoprotein lipase gene in macrophages by dexamethasone. Biochemistry (1991) 0.88
Lipoprotein lipase in cultured pig aortic smooth muscle cells. Arteriosclerosis (1982) 0.87
Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (1981) 10.62
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol (1985) 5.67
Diversity and depth-specific distribution of SAR11 cluster rRNA genes from marine planktonic bacteria. Appl Environ Microbiol (1997) 4.71
The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem (1997) 4.55
Osteopontin is expressed in human aortic valvular lesions. Circulation (1995) 4.16
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J (1996) 4.11
Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest (1991) 3.82
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med (1993) 3.75
The Use of Soluble Starch Medium in the Preparation of Smooth "O" Salmonella Antigens. J Bacteriol (1946) 3.72
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol (1994) 3.57
Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol (1986) 3.50
The causal links between stress and burnout in a longitudinal study of UK doctors. Lancet (2002) 3.45
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34
Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (1989) 3.01
Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A (1992) 2.98
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest (1993) 2.89
The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet (1988) 2.85
Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (1994) 2.79
Hemodynamic regulation: investigation by spectral analysis. Am J Physiol (1985) 2.79
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med (1993) 2.62
Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest (1984) 2.53
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr (2002) 2.49
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A (1998) 2.46
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol (2001) 2.42
Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2000) 2.41
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Antigen chimaeras of poliovirus as potential new vaccines. Nature (1988) 2.38
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35
An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng (1986) 2.31
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest (1986) 2.01
Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol (1986) 1.99
Expression of an Arabidopsis cryptochrome gene in transgenic tobacco results in hypersensitivity to blue, UV-A, and green light. Proc Natl Acad Sci U S A (1995) 1.96
Radiology report production times: voice recognition vs. transcription. Radiol Manage (2001) 1.95
Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother (2006) 1.91
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Children of depressed mothers: maternal strain and symptom predictors of dysfunction. J Abnorm Psychol (1987) 1.83
Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord (1995) 1.83
Temporal gene regulation during HIV-1 infection of human CD4+ T cells. Genome Res (2001) 1.83
Recommendations for the control of Yersinia pestis infections. Recommendations from the CDC. Infect Control (1981) 1.81
Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol (1986) 1.80
BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting. IEEE Trans Med Imaging (2001) 1.79
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol (1989) 1.77
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
Regional studies in skin cancer. 2. Wet tropical and subtropical coasts of Queensland. Med J Aust (1966) 1.75
Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr (1995) 1.73
Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation (1995) 1.73
Studies of intestinal lymphoid tissue. IX. Dose-dependent, gluten-induced lymphoid infiltration of coeliac jejunal epithelium. Scand J Gastroenterol (1985) 1.73
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res (1996) 1.70
Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci U S A (1997) 1.69
Proceedings: Role of prostaglandins in reactions of cellular immunity. Br J Pharmacol (1974) 1.67
Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci U S A (1983) 1.64
The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem (1987) 1.61
Assembly, annotation, and integration of UNIGENE clusters into the human genome draft. Genome Res (2001) 1.60
Construction of the endoplasmic reticulum. J Cell Biol (1989) 1.60
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr (1997) 1.57
Chemical species in fly ash from coal-burning power plants. Science (1980) 1.54
Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr (1998) 1.53
Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry (1988) 1.52
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation (1998) 1.52
The sonopartogram: a novel method for recording progress of labor by ultrasound. Ultrasound Obstet Gynecol (2014) 1.50
Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr (1998) 1.49
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res (1993) 1.49
Effect of physical training on total and visceral fat in obese children. Med Sci Sports Exerc (1999) 1.48
Ascorbic acid clearance in diabetic nephropathy. J Diabetes Complications (1998) 1.47
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res (1983) 1.46
Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A (1996) 1.44
Postnucleation droplet growth in supersaturated gas with arbitrary vapor concentration. J Chem Phys (2004) 1.44
Predictors of change in unmet supportive care needs in cancer. Psychooncology (2010) 1.42
Stress urinary incontinence: prevalence among nulliparous compared with primiparous and grand multiparous premenopausal women. Neurourol Urodyn (1999) 1.42
Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res (1995) 1.42
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci U S A (1989) 1.41
Prostaglandin prophylaxis and bladder function after vaginal hysterectomy: a prospective randomised study. Br J Obstet Gynaecol (1993) 1.41
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol (1985) 1.40
Blood-pressure and its correlates in urban and tribal Africa. Lancet (1980) 1.40
Growth of tracheal anastomoses: advantage of absorbable interrupted sutures. Ann Thorac Surg (1991) 1.40
Prostaglandin production by macrophages and the effect of anti-inflammatory drugs. Br J Pharmacol (1978) 1.40
Best practice and enterprise bargaining. J Qual Clin Pract (1995) 1.39
Non-metallic foreign bodies. Br J Radiol (1985) 1.39